Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial

Published:2018-09 Issue:4 Volume:8 Page:1-7
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Richter Manuel J.¹,Stollfuß Barbara²,Roitenberg Alexander²,Kleinjung Frank³,Graeff Valentin⁴,Berghaus Sabine²,Müller Christian²,Ghofrani Hossein‐Ardeschir¹⁵⁶

Affiliation:

1. Department of Internal MedicineJustus Liebig University GiessenUniversities of Giessen and Marburg Lung Center (UGMLC)member of the German Center for Lung Research (DZL)GiessenGermany

2. Bayer Vital GmbHLeverkusenGermany

3. Bayer AGBerlinGermany

4. ContraCare GmbHNurembergGermany

5. University of Giessen and Marburg Lung Center (UGMLC)member of the German Center for Lung Research (DZL)GiessenGermany

6. Department of MedicineImperial College LondonLondonUK

Funder

Bayer AG

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894018798921

Reference19 articles.

1. Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options;Rosenkranz S;Clin Res Cardiol,2015

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galiè N;Eur Heart J,2016

3. The right ventricle under pressure: evaluating the adaptive and maladaptive changes in the right ventricle in pulmonary arterial hypertension using echocardiography (2013 Grover Conference series);Harrison A;Pulm Circ,2015

4. Prostanoid therapies in the management of pulmonary arterial hypertension;LeVarge BL;Ther Clin Risk Manag,2015

5. Prostacyclin therapies for the treatment of pulmonary arterial hypertension;Gomberg‐Maitland M;Eur Respir J,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Respiratory Distress Syndrome and the Use of Inhaled Pulmonary Vasodilators in the COVID-19 Era: A Narrative Review;Life;2022-11-02

2. Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study;The Anatolian Journal of Cardiology;2021-10-06

3. The Effects of Iloprost on Oxygenation During One-Lung Ventilation for Lung Surgery: A Randomized Controlled Trial;Journal of Clinical Medicine;2019-07-05

4. Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study;Pulmonary Circulation;2019-07

5. Inhalation Drug Therapy: Emerging Trends in Nasal and Pulmonary Drug Delivery;Novel Drug Delivery Technologies;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3